Epigenetic architecture and miRNA: Reciprocal regulators

Epigenomics

Volumn 2, Issue 6, 2010, Pages 823-840

  Wiklund, Erik D ^a,b   Kjems, Jørgen ^a   Clark, Susan J ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

cancer; chromatin; DNA methylation; epigenetics; gene regulation; histone modification; miRNA; ncRNA; transcriptional gene silencing

Indexed keywords

MICRORNA; SMALL INTERFERING RNA; UNTRANSLATED RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BIOGENESIS; CHROMATIN STRUCTURE; DNA METHYLATION; ENZYME REPRESSION; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; GENE STRUCTURE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; RNA INTERFERENCE; RNA PROCESSING; RNA STABILITY; RNA TRANSCRIPTION;

ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; HUMANS; MICRORNAS; MODELS, GENETIC; NEOPLASMS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA INTERFERENCE;

EID: 78650437816     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.51     Document Type: Review

References (182)

1. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A: An operational definition of epigenetics. Genes Dev. 23(7), 781-783 (2009).
2. Jones PA, Laird PW: Cancer epigenetics comes of age. Nat. Genet. 21(2), 163-167 (1999).
3. Gronbaek K, Hother C, Jones PA: Epigenetic changes in cancer. APMIS 115(10), 1039-1059 (2007).
4. Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis 31(1), 27-36 (2010).
5. No authors listed. Time for the epigenome. Nature , 463(7281), 587(2010).
6. Wilson AS, Power BE, Molloy PL: DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775(1), 138-162 (2007).
7. Ross JP, Rand KN, Molloy PL: Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2(2), 245-269 (2010).
8. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M: DNA methylation: bisulphite modification and analysis. Nat. Protoc. 1(5), 2353-2364 (2006).
9. Laird PW: Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 11(3), 191-203 (2010).
10. Baylin S, Bestor TH: Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1(4), 299-305 (2002).
11. Clark SJ, Melki J: DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21(35), 5380-5387 (2002).
12. Wilhelm BT, Marguerat S, Watt S et al.: Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution. Nature 453(7199), 1239-1243 (2008).
13. Preker P, Nielsen J, Kammler S et al.: RNA exosome depletion reveals transcription upstream of active human promoters. Science 322(5909), 1851-1854 (2008).
14. Seila AC, Calabrese JM, Levine SS et al.: Divergent transcription from active promoters. Science 322(5909), 1849-1851 (2008).
15. Mercer TR, Dinger ME, Mattick JS: Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10(3), 155-159 (2009).
16. Costa FF: Non-coding RNAs: meet thy masters. Bioessays 32(7), 599-608 (2010).
17. Grewal SI, Jia S: Heterochromatin revisited. Nat. Rev. Genet. 8(1), 35-46 (2007).
18. Grewal SI: RNAi-dependent formation of heterochromatin and its diverse functions. Curr. Opin. Genet. Dev. 20(2), 134-141 (2010).
19. Brennecke J, Malone CD, Aravin AA, Sachidanandam R, Stark A, Hannon GJ: An epigenetic role for maternally inherited piRNAs in transposon silencing. Science 322(5906), 1387-1392 (2008).
20. Kuramochi-Miyagawa S, Watanabe T, Gotoh K et al.: DNA methylation of retrotransposon genes is regulated by PIWI family members MILI and MIWI2 in murine fetal testes. Genes Dev. 22(7), 908-917 (2008).
21. Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG: Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 4(11), E1000258 (2008).
22. Han J, Kim D, Morris KV: Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl Acad. Sci. USA 104(30), 12422-12427 (2007).
23. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281-297 (2004).
24. Guil S, Esteller M: DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell. Biol. 41(1), 87-95 (2009).
25. Mallanna SK, Rizzino A: Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev. Biol. 344(1), 16-25 (2010).
26. Brennecke J, Stark A, Russell RB, Cohen SM: Principles of microRNA-target recognition. PLoS Biol. 3(3), E85 (2005).
27. Asli NS, Pitulescu ME, Kessel M: MicroRNAs in organogenesis and disease. Curr. Mol. Med. 8(8), 698-710 (2008).
28. Weber B, Stresemann C, Brueckner B, Lyko F: Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6(9), 1001-1005 (2007).
29. Newman MA, Hammond SM: Emerging paradigms of regulated microRNA processing. Genes Dev. 24(11), 1086-1092 (2010).
30. Yang N, Coukos G, Zhang L: MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int. J. Cancer 122(5), 963-968 (2008).
31. Siomi H, Siomi MC: Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 38(3), 323-332 (2010).
32. Barski A, Jothi R, Cuddapah S et al.: Chromatin poises miRNA-and protein-coding genes for expression. Genome Res. 19(10), 1742-1751 (2009).
33. Ozsolak F, Poling LL, Wang Z et al.: Chromatin structure analyses identify miRNA promoters. Genes Dev. 22(22), 3172-3183 (2008).
34. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV: Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 4(4), E5279 (2009).
35. Kanwar JR, Mahidhara G, Kanwar RK: MicroRNA in human cancer and chronic inflammatory diseases. Front. Biosci. (Schol. Ed.) 2, 1113-1126 (2010).
36. Wang Y, Keys DN, Au-Young JK, Chen C: MicroRNAs in embryonic stem cells. J. Cell. Physiol. 218(2), 251-255 (2009).
37. Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ: MiRBase: tools for microRNA genomics. Nucleic Acids Res. 36(Database issue), D154-D158 (2008).
38. Mitchell PS, Parkin RK, Kroh EM et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105(30), 10513-10518 (2008).
39. Slack FJ, Weidhaas JB: MicroRNAs as a potential magic bullet in cancer. Future Oncol. 2(1), 73-82 (2006).
40. Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6(4), 259-269 (2006).
41. Calin GA, Sevignani C, Dumitru CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101(9), 2999-3004 (2004).
42. Ryan BM, Robles AI, Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 10(6), 389-402 (2010).
43. Chang TC, Yu D, Lee YS et al.: Widespread microRNA repression by myc contributes to tumorigenesis. Nat. Genet. 40(1), 43-50 (2008).
44. Burk U, Schubert J, Wellner U et al.: A reciprocal repression between ZEB1 and members of the miR-200 family promotes Emt and invasion in cancer cells. EMBO Rep. 9(6), 582-589 (2008).
45. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449(7163), 682-688 (2007).
46. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB: Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res. 37(1), 123-128 (2009).
47. Cao P, Deng Z, Wan M et al.: MicroRNA-101 negatively regulates EZH2 and its expression is modulated by androgen receptor and HIF-1a/HIF-1b. Mol. Cancer 9, 108 (2010).
48. He L, He X, Lim LP et al.: A microRNA component of the p53 tumour suppressor network. Nature 447(7148), 1130-1134 (2007).
49. Emmrich S, Putzer BM: Checks and balances: E2f-microRNA crosstalk in cancer control. Cell Cycle 9, 13 (2010).
50. Pulikkan JA, Dengler V, Peramangalam PS et al.: Cell-cycle regulator e2f1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 115(9), 1768-1778 (2010).
51. Davalos V, Esteller M: MicroRNAs and cancer epigenetics: a macrorevolution. Curr. Opin. Oncol. 22(1), 35-45 (2010).
52. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K: Modulation of microRNA processing by p53. Nature 460(7254), 529-533 (2009).
53. Kuchen S, Resch W, Yamane A et al.: Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32, 1-12 (2010).
54. Ku M, Koche RP, Rheinbay E et al.: Genomewide analysis of prc1 and prc2 occupancy identifies two classes of bivalent domains. PLoS Genet. 4(10), E1000242 (2008).
55. Morlando M, Ballarino M, Gromak N, Pagano F, Bozzoni I, Proudfoot NJ: Primary microRNA transcripts are processed co-transcriptionally. Nat. Struct. Mol. Biol. 15(9), 902-909 (2008).
56. Iorio MV, Piovan C, Croce CM: Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim. Biophys. Acta doi: 10.1016/j.bbagrm.2010.05.005 (2010) (Epub ahead of print).
57. Saito Y, Liang G, Egger G et al.: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6), 435-443 (2006).
58. Datta J, Kutay H, Nasser MW et al.: Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 68(13), 5049-5058 (2008)
59. Saito Y, Suzuki H, Tsugawa H et al.: Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28(30), 2738-2744 (2009).
60. Brueckner B, Stresemann C, Kuner R et al.: The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67(4), 1419-1423 (2007).
61. Lujambio A, Ropero S, Ballestar E et al.: Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67(4), 1424-1429 (2007).
62. Szulwach KE, Li X, Smrt RD et al.: Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 189(1), 127-141 (2010).
63. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH: Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 10(12), 1513-1514 (2007).
64. Nomura T, Kimura M, Horii T et al.: MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 17(8), 1192-1199 (2008).
65. Bueno MJ, Perez De Castro I, Gomez De Cedron M et al.: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13(6), 496-506 (2008).
66. Wiklund ED, Bramsen JB, Hulf T et al.: Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer doi: 10.1002/ ijc.25461 (2010) (Epub ahead of print).
67. Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E: MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 31(5), 864-870 (2010).
68. Corney DC, Hwang CI, Matoso A et al.: Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 16(4), 1119-1128 (2010).
69. Hsu PY, Deatherage De, Rodriguez BA et al.: Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69(14), 5936-5945 (2009).
70. Lu L, Katsaros D, De La Longrais IA, Sochirca O, Yu H: Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67(21), 10117-10122 (2007).
71. Bandres E, Agirre X, Bitarte N et al.: Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 125(11), 2737-2743 (2009).
72. Huang YW, Liu JC, Deatherage DE et al.: Epigenetic repression of microRNA-129-2 leads to overexpression of sox4 oncogene in endometrial cancer. Cancer Res. 69(23), 9038-9046 (2009).
73. Hanoun N, Delpu Y, Suriawinata AA et al.: The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 56(7), 1107-1118 (2010).
74. Lehmann U, Hasemeier B, Christgen M et al.: Epigenetic inactivation of microRNA gene HSA-miR-9-1 in human breast cancer. J. Pathol. 214(1), 17-24 (2008).
75. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J: Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68(7), 2094-2105 (2008).
76. Roman-Gomez J, Agirre X, Jimenez-Velasco A et al.: Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J. Clin. Oncol. 27(8), 1316-1322 (2009).
77. Lujambio A, Calin GA, Villanueva A et al.: A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105(36), 13556-13561 (2008).
78. Iorio MV, Visone R, Di Leva G et al.: MicroRNA signatures in human ovarian cancer. Cancer Res. 67(18), 8699-8707 (2007).
79. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A et al.: Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates cdk6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69(10), 4443-4453 (2009).
80. Toyota M, Suzuki H, Sasaki Y et al.: Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68(11), 4123-4132 (2008).
81. Tsai KW, Hu LY, Wu CW et al.: Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosomes Cancer 49(11), 969-980 (2010).
82. Li A, Omura N, Hong SM et al.: Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 70(13), 5226-5237 (2010).
83. Gregory PA, Bert AG, Paterson EL et al.: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10(5), 593-601 (2008).
84. Park SM, Gaur AB, Lengyel E, Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22(7), 894-907 (2008).
85. Shimono Y, Zabala M, Cho RW et al.: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3), 592-603 (2009).
86. Wellner U, Schubert J, Burk UC et al.: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11(12), 1487-1495 (2009).
87. Peter ME: Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression. Cell Cycle 8(6), 843-852 (2009).
88. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA: Stat3-and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl Acad. Sci. USA 102(19), 6948-6953 (2005).
89. Brenner C, Deplus R, Didelot C et al.: Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24(2), 336-346 (2005).
90. Di Croce L, Raker VA, Corsaro M et al.: Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295(5557), 1079-1082 (2002).
91. Fazi F, Racanicchi S, Zardo G et al.: Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12(5), 457-466 (2007).
92. Collas P: The current state of chromatin immunoprecipitation. Mol. Biotechnol. 45(1), 87-100 (2010).
93. Lujambio A, Esteller M: CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6(12), 1455-1459 (2007).
94. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ: Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res. 35(18), E119 (2007).
95. Vrba L, Jensen TJ, Garbe JC et al.: Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 5(1), E8697 (2010).
96. Robinson M, Statham AL, Stirzaker C, Speed TP, Clark SJ: Protocol matters: which methylome are you actually studying? Epigenomics 2, 587-598 (2010).
97. Lister R, OMalley RC, Tonti-Filippini J et al.: Highly integrated single-base resolution maps of the epigenome in arabidopsis. Cell 133(3), 523-536 (2008).
98. Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008).
99. Lister R, Pelizzola M, Dowen RH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
100. Laurent L, Wong E, Li G et al.: Dynamic changes in the human methylome during differentiation. Genome Res. 20(3), 320-331 (2010).
101. Flusberg BA, Webster DR, Lee JH et al.: Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat. Methods 7(6), 461-465 (2010).
102. Robinson MD, Statham AL, Speed TP, Clark SJ: Protocol matters: which methylome are you actually studying? Epigenomics 2(4), 587-598 (2010).
103. Fabbri M, Garzon R, Cimmino A et al.: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3a and 3b. Proc. Natl Acad. Sci. USA 104(40), 15805-15810 (2007).
104. Garzon R, Liu S, Fabbri M et al.: MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3a and 3b and indirectly DNMT1. Blood 113(25), 6411-6418 (2009).
105. Ng EK, Tsang WP, Ng SS et al.: MicroRNA-143 targets DNA methyltransferases 3a in colorectal cancer. Br. J. Cancer 101(4), 699-706 (2009).
106. Duursma AM, Kedde M, Schrier M, Le Sage C, Agami R: Mir-148 targets human DNMT3b protein coding region. RNA 14(5), 872-877 (2008).
107. Braconi C, Huang N, Patel T: MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51(3), 881-890 (2010).
108. Ostenfeld MS, Bramsen JB, Lamy P et al.: Mir-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in TA bladder tumors. Oncogene 29(7), 1073-1084 (2010).
109. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T: Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 98(12), 1914-1920 (2007).
110. Girault I, Tozlu S, Lidereau R, Bieche I: Expression analysis of DNA methyltransferases 1, 3a, and 3b in sporadic breast carcinomas. Clin. Cancer Res. 9(12), 4415-4422 (2003).
111. Sinkkonen L, Hugenschmidt T, Berninger P et al.: MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15(3), 259-267 (2008).
112. Varambally S, Cao Q, Mani RS et al.: Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322(5908), 1695-1699 (2008).
113. Friedman JM, Liang G, Liu CC et al.: The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 69(6), 2623-2629 (2009).
114. Wong CF, Tellam RL: MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J. Biol. Chem. 283(15), 9836-9843 (2008).
115. Tamminga J, Kathiria P, Koturbash I, Kovalchuk O: DNA damage-induced upregulation of miR-709 in the germline downregulates boris to counteract aberrant DNA hypomethylation. Cell Cycle 7(23), 3731-3736 (2008).
116. Chen JF, Mandel EM, Thomson JM et al.: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38(2), 228-233 (2006).
117. Noonan EJ, Place RF, Pookot D et al.: miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28(14), 1714-1724 (2009).
118. Orom UA, Lund AH: Experimental identification of microRNA targets. Gene 451(1-2), 1-5 (2010).
119. Matzke MA, Birchler JA: RNAi-mediated pathways in the nucleus. Nat. Rev. Genet. 6(1), 24-35 (2005).
120. Suzuki K, Kelleher AD: Transcriptional regulation by promoter targeted RNAs. Curr. Top. Med. Chem. 9(12), 1079-1087 (2009).
121. Wassenegger M, Heimes S, Riedel L, Sanger HL: RNA-directed de novo methylation of genomic sequences in plants. Cell 76(3), 567-576 (1994).
122. Molnar A, Melnyk CW, Bassett A, Hardcastle TJ, Dunn R, Baulcombe DC: Small silencing RNAs in plants are mobile and direct epigenetic modification in recipient cells. Science 328(5980), 872-875 (2010).
123. Wassenegger M: RNA-directed DNA methylation. Plant Mol. Biol. 43(2-3), 203-220 (2000).
124. Aufsatz W, Mette MF, Van Der Winden J, Matzke AJ, Matzke M: RNA-directed DNA methylation in Arabidopsis. Proc. Natl Acad. Sci. USA 99(Suppl. 4), 16499-16506 (2002).
125. Jones L, Hamilton AJ, Voinnet O, Thomas CL, Maule AJ, Baulcombe DC: RNA-DNA interactions and DNA methylation in post-transcriptional gene silencing. Plant Cell 11(12), 2291-2301 (1999).
126. Mette MF, Aufsatz W, Van Der Winden J, Matzke MA, Matzke AJ: Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J. 19(19), 5194-5201 (2000).
127. Huettel B, Kanno T, Daxinger L et al.: RNA-directed DNA methylation mediated by DRD1 and Pol IVb: A versatile pathway for transcriptional gene silencing in plants. Biochim. Biophys. Acta 1769(5-6), 358-374 (2007).
128. Wu L, Zhou H, Zhang Q et al.: DNA methylation mediated by a microRNA pathway. Mol. Cell 38(3), 465-475 (2010).
129. Khraiwesh B, Arif MA, Seumel GI et al.: Transcriptional control of gene expression by microRNAs. Cell 140(1), 111-122 (2010).
130. Verdel A, Jia S, Gerber S et al.: RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303(5658), 672-676 (2004).
131. Malecova B, Morris KV: Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr. Opin. Mol. Ther. 12(2), 214-222 (2010)
132. Ting AH, Schuebel KE, Herman JG, Baylin SB: Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet. 37(8), 906-910 (2005).
133. Weinberg MS, Villeneuve LM, Ehsani A et al.: The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12(2), 256-262 (2006).
134. Gonzalez S, Pisano DG, Serrano M: Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle 7(16), 2601-2608 (2008).
135. Kim DH, Villeneuve LM, Morris KV, Rossi JJ: Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13(9), 793-797 (2006).
136. Janowski BA, Huffman KE, Schwartz JC et al.: Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol. 1(4), 216-222 (2005).
137. Morris KV, Chan SW, Jacobsen SE, Looney DJ: Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305(5688), 1289-1292 (2004).
138. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV: Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res. 37(9), 2984-2995 (2009).
139. Janowski BA, Huffman KE, Schwartz JC et al.: Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat. Struct. Mol. Biol. 13(9), 787-792 (2006).
140. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T: DNMT3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20(10), 2536-2544 (2001).
141. Vire E, Brenner C, Deplus R et al.: The polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078), 871-874 (2006).
142. Kim DH, Saetrom P, Snove O Jr, Rossi JJ: MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA 105(42), 16230-16235 (2008).
143. Vasudevan S, Tong Y, Steitz JA: Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318(5858), 1931-1934 (2007).
144. Li LC, Okino ST, Zhao H et al.: Small dsRNAs induce transcriptional activation in human cells. Proc. Natl Acad. Sci. USA 103(46), 17337-17342 (2006).
145. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR: Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol. 3(3), 166-173 (2007).
146. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R: MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA 105(5), 1608-1613 (2008).
147. Schwartz JC, Younger ST, Nguyen NB et al.: Antisense transcripts are targets for activating small RNAs. Nat. Struct. Mol. Biol. 15(8), 842-848 (2008).
148. Morin RD, OConnor MD, Griffith M et al.: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 18(4), 610-621 (2008).
149. Yu W, Gius D, Onyango P et al.: Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451(7175), 202-206 (2008).
150. Allo M, Buggiano V, Fededa JP et al.: Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol. 16(7), 717-724 (2009).
151. Budhu A, Jia HL, Forgues M et al.: Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47(3), 897-907 (2008).
152. Gottardo F, Liu CG, Ferracin M et al.: Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25(5), 387-392 (2007).
153. Baffa R, Fassan M, Volinia S et al.: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 219(2), 214-221 (2009).
154. Schetter AJ, Leung SY, Sohn JJ et al.: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4), 425-436 (2008).
155. Raponi M, Dossey L, Jatkoe T et al.: MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69(14), 5776-5783 (2009).
156. Mi S, Lu J, Sun M et al.: MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl Acad. Sci. USA 104(50), 19971-19976 (2007).
157. Hummel R, Hussey DJ, Haier J: MicroRNAs: Predictors and modifiers of chemo-and radiotherapy in different tumour types. Eur. J. Cancer 46(2), 298-311 (2010).
158. Brase JC, Johannes M, Schlomm T et al.: Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer doi: 10.1002/ijc.25376 (2010) (Epub ahead of print).
159. Ferracin M, Veronese A, Negrini M: Micromarkers: MiRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn. 10(3), 297-308 (2010).
160. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B: Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4(7), E6229 (2009).
161. Xie Y, Todd NW, Liu Z et al.: Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67(2), 170-176 (2010).
162. Tanaka M, Oikawa K, Takanashi M et al.: Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 4(5), E5532 (2009).
163. Castanotto D, Rossi JJ: The promises and pitfalls of RNA-interference- based therapeutics. Nature 457(7228), 426-433 (2009).
164. Elmen J, Lindow M, Schutz S et al.: LNA-mediated microRNA silencing in non-human primates. Nature 452(7189), 896-899 (2008).
165. Lanford RE, Hildebrandt-Eriksen ES, Petri A et al.: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962), 198-201 (2010).
166. Davis ME, Zuckerman JE, Choi CH et al.: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291), 1067-1070 (2010).
167. Lu Y, Xiao J, Lin H et al.: A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res. 37(3), E24 (2009).
168. Cortez CC, Jones PA: Chromatin, cancer and drug therapies. Mutat. Res. 647(1-2), 44-51 (2008).
169. Yamagishi M, Ishida T, Miyake A et al.: Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect. 11(4), 500-508 (2009).
170. Viswanathan SR, Daley GQ, Gregory RI: Selective blockade of microRNA processing by Lin28. Science 320(5872), 97-100 (2008).
171. Lee YS, Dutta A: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21(9), 1025-1030 (2007).
172. Guo LM, Pu Y, Han Z et al.: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kB1. FEBS J. 276(19), 5537-5546 (2009).
173. Huse JT, Brennan C, Hambardzumyan D et al.: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23(11), 1327-1337 (2009).
174. Zhang X, Liu S, Hu T, He Y, Sun S: Up-regulated microRNA-143 transcribed by nuclear factor kB enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50(2), 490-499 (2009).
175. Zaman MS, Chen Y, Deng G et al.: The functional significance of microRNA-145 in prostate cancer. Br. J. Cancer 103(2), 256-264 (2010).
176. Pan W, Zhu S, Yuan M et al.: MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ t cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184(12), 6773-6781 (2010).
177. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y: Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 31(5), 777-784 (2010).
178. Popovic R, Riesbeck LE, Velu CS et al.: Regulation of miR-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113(14), 3314-3322 (2009).
179. Song H, Bu G: MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem. Biophys. Res. Commun. 388(2), 400-405 (2009).
180. Iorio MV, Casalini P, Piovan C et al.: microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 69(6), 2195-2200 (2009).
181. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y: Mir-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J. 24(6), 2030-2039 (2010).
182. Sun G, Li H, Rossi JJ: Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3UTR. Nucleic Acids Res. 38(1), 239-252 (2010).